Axogen, Inc. — Director's Dealing 2017

Mar 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2017-03-14

Reporting Person: DeVinney Erick Wayne (VP, Clinical&Translational Sc)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-14	Common Stock	M	4659	$0.27	Acquired	4659	Direct
2017-03-14	Common Stock	M	359	$0.27	Acquired	5018	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-14	Employee Stock Option (right to purchase)	$0.27	M	4659	Acquired	2017-04-25	Common Stock (4659)	Direct
2017-03-14	Employee Stock Option (right to purchase)	$0.27	M	359	Acquired	2017-12-06	Common Stock (359)	Direct